ANDA 77098, held by Dr Reddys Labs Ltd. Ofloxacin.
As of Nov 16, 2026, ANDA 77098 (Ofloxacin), held by Dr Reddys Labs Ltd, was first approved by FDA on Feb 10, 2006, with 12 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 10, 2006 | Original application | Approved | None posted |
| May 3, 2019 | Supplement 12Labeling · Standard review | Approved | None posted |
| Oct 18, 2018 | Supplement 11Labeling · Standard review | Approved | None posted |
| Jul 26, 2016 | Supplement 10Labeling · Standard review | Approved | None posted |
| Aug 14, 2013 | Supplement 9Labeling · Standard review | Approved | None posted |
| Aug 13, 2013 | Supplement 5REMS | Approved | None posted |
| Aug 13, 2013 | Supplement 7REMS | Approved | None posted |
| Aug 13, 2013 | Supplement 8REMS | Approved | None posted |
| Mar 10, 2011 | Supplement 6Labeling | Approved | None posted |
| Apr 21, 2010 | Supplement 4Labeling | Approved | None posted |
| Dec 19, 2008 | Supplement 3Labeling | Approved | None posted |
| Aug 14, 2007 | Supplement 2Labeling | Approved | None posted |
| Oct 17, 2006 | Supplement 1Labeling | Approved | None posted |
| Feb 10, 2006 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters